How many people have successfully stopped taking Eltrombopag/Eltrombopag?

Eltrombopag/ Eltrombopag is an effective drug for the treatment of thrombocytopenia, but the success rate of discontinuation varies among individuals. Studies have shown that under certain conditions, such as patients with normal liver function, the drug can be stopped after three months of use. However, in patients with abnormal liver function, longer treatment may be required, and the drug may even need to be discontinued after six months. In addition, the success rate of discontinuation may be affected by other factors, such as the patient's overall health, comorbidities, and medication compliance. Therefore, the exact success rate of discontinuation cannot be given.